We accidentally made dogs age too fast. Now a biotech founder is fixing it. @celinehalioua’s @loyalfordogs is running the largest veterinary clinical trial ever to extend dog lifespans—and it might just work.

Founder & CEO @celinehalioua takes @abundanceinst inside what could be the first FDA-approved longevity drug and shares a glimpse into her vision for Loyal, longevity, and our four-legged friends.

“If we bring this drug to market, we’ll be able to tie my effort and my team’s effort to potentially millions of dog years gained.” https://t.co/3q2AWG20Iq

From our progress towards approval to what's next for longevity, Founder & CEO @celinehalioua covered it all on the latest episode of @corememory. Tune in to hear her wide-ranging conversation with @ashleevance here:

Ever wonder what it takes to turn a love for dogs into a biotech company? @celinehalioua shares how @loyalfordogs is redefining what’s possible in animal health. 🎧 Fetch the full episode → https://t.co/WK30qMr7j1 #TheRoomPodcast #LoyalForDogs #Founders

From early conversations around a campfire that led to our founding all the way to our work today and vision for the future, hear Founder & CEO @celinehalioua cover everything Loyal on @The_RoomPodcast with @claudiaclaurie and @MadsMcIlwain: https://t.co/7ijEtajUYA

Ever wondered how our Founder & CEO @celinehalioua thinks about drug development, AI, and the future of longevity? She sat down with @jordihays and @johncoogan from @tbpn yesterday to unpack it all. Tune in at 1:56 to hear the scoop:

Why do bigger dogs have shorter lifespans? @celinehalioua, founder and CEO of dog longevity company @loyalfordogs, explains how understanding why is key to treatments that help them live longer.

Loyal CEO @celinehalioua explains why there will never be a market for an Ozempic-like drug for dogs, even though it would be good for them.

Will pharmaceutical companies double down on GLP-1s and preventative care, over other R&D they may have planned? At Deus Ex Medicina, @nayeema posed the question to @celinehalioua, founder and CEO of @loyalfordogs. Here's what she said:

https://t.co/ZOGKOpewwe

How has our understanding of longevity and aging evolved? And how is it transforming biotech startups today? Our Founder and CEO @celinehalioua is joining Co-founder of @noom @saejujeong and @nayeema tomorrow @NewcomerMedia's Deus Ex Medicina to discuss drug development's role:

Read more from Dr. Brennen McKenzie at

We’ve published the first-ever data that connects these markers of metabolic aging to real-world clinical outcomes in dogs like frailty and quality of life. We’re beginning to understand these as “early indicators” or “red flags” for unhealthy aging patterns.

Did you know your dog’s lab values can tell us a lot about how they’re aging? While changes in these values may be invisible, they have real clinical significance for dogs.

Our Founder & CEO @celinehalioua and Director of Veterinary Medicine @SkeptVet recently sat down with @Forbes to answer all your questions. Watch the interview here:

Have you ever wanted to peek behind the scenes of a longevity startup? Or are you curious about why we’re working on dog lifespan extension?

Forbes announced the 2025 Next Billion-Dollar Startups List. So excited to see eight @BoxGroup portfolio companies highlighted on this year's list, representing over 30% of the group. Congratulations to Basis (@trybasis), Braintrust (@usebraintrust), David AI (@withdavidai),

Longer Leash On Life: Inside The Dog Longevity Startup https://t.co/JYZBlAHfTr

We’re proud to see two portfolio companies—@krea_ai and @loyalfordogs—named to @Forbes' Next Billion-Dollar Startups list. Krea 🎨 A platform for creatives to generate & edit images & videos so they have the speed and control to bring ideas to life. Loyal 🐶 Extending dogs’